NCT05547074View on ClinicalTrials.gov

A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

302

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

October 30, 2020

Study Completion Date

August 31, 2022

Conditions
Neoplasms Pancreatic
Interventions
PROCEDURE

pancreatic cancer surgery

Surgical resection of pancreatic cancer，including radical or palliative surgery

Trial Locations (1)

310003

First Affiliated Hospital, Medical College of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT05547074 - A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma | Biotech Hunter | Biotech Hunter